- Home
- MDRR vs DYAI Comparison
MDRR vs DYAI Comparison
Compare MDRR & DYAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MDRR | DYAI |
|---|---|---|
| Founded | 2015 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.3M | 17.0M |
| IPO Year | 2015 | 2026 |
Fundamental Metrics
Financial Performance| Metric | MDRR | DYAI |
|---|---|---|
| Price | $10.51 | $0.44 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 5.7K | ★ 179.7K |
| Earning Date | 11-05-2026 | 11-11-2026 |
| Dividend Yield | ★ 2.68% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 4.74 | N/A |
| Revenue | ★ $10,396,618.00 | $3,090,345.00 |
| Revenue This Year | $0.91 | $113.16 |
| Revenue Next Year | $1.70 | $94.92 |
| P/E Ratio | $2.13 | ★ N/A |
| Revenue Growth | ★ 6.79 | N/A |
| 52 Week Low | $9.47 | $0.34 |
| 52 Week High | $14.52 | $1.60 |
Technical Indicators
Market Signals| Indicator | MDRR | DYAI |
|---|---|---|
| Relative Strength Index (RSI) | 43.22 | 39.53 |
| Support Level | $9.47 | $0.34 |
| Resistance Level | $12.31 | $0.50 |
| Average True Range (ATR) | 0.50 | 0.04 |
| MACD | -0.18 | 0.02 |
| Stochastic Oscillator | 27.63 | 56.77 |
Price Performance
Historical ComparisonAbout MDRR Medalist Diversified REIT Inc.
Medalist Diversified Inc owns ten investment properties comprised of three retail properties, three flex/industrial properties, and four STNL properties, including the Tesla Pensacola Property. Through its subsidiary, the company sponsors Delaware Statutory Trusts (DSTs) that provide accredited investors access to institutional-quality real estate with the transparency and governance of a public company. The company has three reportable segments, consisting of retail center properties, flex center properties, and STNL properties. The company generates the majority of its revenue from the Retail Center Property.
About DYAI Dyadic International Inc.
Dyadic International Inc is a biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1.